Scientists Discover Why MS Damages Brain's Thinking Center

Scientists at UC San Francisco, University of Cambridge, and Cedars-Sinai Medical Center have finally cracked a puzzle that's stumped MS researchers for decades: why the disease damages not just nerve connections, but the brain cells that control thinking itself.

The team discovered that inflammation in MS triggers DNA damage in a specific type of neuron called CUX2 neurons, which live in the brain's gray matter and handle higher cognitive functions like memory and problem-solving. These neurons try to repair themselves, but the inflammation overwhelms their natural defense systems, causing them to die.

The finding explains why brain scans of MS patients show damage beyond the white matter that researchers have focused on for years. While white matter acts like the brain's wiring, gray matter houses the actual computing power.

"We've had remarkable success developing therapies to slow the loss of myelin during MS, but grey matter lesions and the disability they cause have been harder to address," said Stephen Hauser, who directs the UCSF Weill Institute for Neurosciences.

The researchers tested their discovery in mouse models and found matching evidence in brain tissue from people with MS. The April 2026 study, published in Nature, marks the first time scientists have traced the exact chemical pathway from inflammation to neuron death in MS.

The Bright Side

This discovery shifts the entire MS research landscape in an exciting direction. For years, treatments focused solely on rebuilding myelin, the protective coating around nerves. Now scientists have a clear target for protecting the brain's thinking centers directly.

David Rowitch from the University of Cambridge calls these CUX2 neurons "a canary in the coal mine" for MS. Protecting them could stop disease progression before serious damage occurs.

The research team is already working on therapies to shield these vulnerable neurons from inflammation's effects. Combined with existing myelin treatments, this dual approach could preserve both brain connections and cognitive function in MS patients.

For the 2.8 million people worldwide living with MS, this breakthrough offers genuine hope for protecting the abilities that matter most in daily life: memory, thinking, and decision-making.